DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-87.58%
US · US
FIS.US latest organized financial period shows revenue grew +311% YoY and net income grew +35.94% YoY. Current price is about 46.08 USD, while the model base case is about 23.16 USD; the current price sits +99% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:28
Hover each model row to inspect formulas and inputs.
+98.96%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-87.58%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+98.96%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -10.0% annualized FCF growth.
Estimates earnings power value without assuming growth.
+221%
Updated: 2026/04/29 15:28
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -14M USD | Medium |
| 2025/12/31 | Business sale gain/loss | Asset sale gain/loss | -94M USD | Medium |
| 2025/12/31 | Integration and restructuring costs | Restructuring | -107M USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -82M USD | Medium |
| 2024/12/31 | Business sale gain/loss | Asset sale gain/loss | -98M USD | Medium |
| 2024/12/31 | Discontinued operations | Discontinued operations | 1B USD | High |
| 2024/12/31 | Integration and restructuring costs | Restructuring | -139M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -268M USD | Medium |
| 2023/12/31 | Business sale gain/loss | Asset sale gain/loss | -230M USD | Medium |
| 2023/12/31 | Discontinued operations | Discontinued operations | -21B USD | High |
| 2023/12/31 | Integration and restructuring costs | Restructuring | -114M USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -81M USD | Medium |
| 2022/12/31 | Special income/charges | Other | -81M USD | Medium |
| 2022/12/31 | Write-off | Impairment | -14B USD | Medium |
| 2021/12/31 | Write-off | Impairment | -160M USD | Medium |
| 2025/09/30 | Asset impairment | Impairment | -5M USD | Medium |
| 2025/09/30 | Business sale gain/loss | Asset sale gain/loss | -77M USD | Medium |
| 2025/09/30 | Integration and restructuring costs | Restructuring | -92M USD | Medium |
| 2025/06/30 | Asset impairment | Impairment | -2M USD | Medium |
| 2025/06/30 | Business sale gain/loss | Asset sale gain/loss | -79M USD | Medium |
| 2025/06/30 | Integration and restructuring costs | Restructuring | -74M USD | Medium |
| 2025/03/31 | Asset impairment | Impairment | -2M USD | Medium |
| 2025/03/31 | Business sale gain/loss | Asset sale gain/loss | -24M USD | Medium |
| 2025/03/31 | Integration and restructuring costs | Restructuring | -6M USD | Medium |
| 2024/12/31 | Discontinued operations | Discontinued operations | -23M USD | High |
| 2024/09/30 | Asset impairment | Impairment | -35M USD | Medium |
| 2024/09/30 | Business sale gain/loss | Asset sale gain/loss | -122M USD | Medium |
| 2024/09/30 | Discontinued operations | Discontinued operations | 1B USD | High |
| 2024/09/30 | Integration and restructuring costs | Restructuring | -145M USD | Medium |
| 2024/06/30 | Asset impairment | Impairment | -35M USD | Medium |
| 2024/06/30 | Business sale gain/loss | Asset sale gain/loss | -51M USD | Medium |
| 2024/06/30 | Discontinued operations | Discontinued operations | 1B USD | High |
| 2024/06/30 | Integration and restructuring costs | Restructuring | -115M USD | Medium |
| 2024/03/31 | Asset impairment | Impairment | -22M USD | Medium |
| 2024/03/31 | Business sale gain/loss | Asset sale gain/loss | -22M USD | Medium |
| 2024/03/31 | Discontinued operations | Discontinued operations | 2B USD | High |
| 2024/03/31 | Integration and restructuring costs | Restructuring | -38M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 11B USD | 382M USD | 598M USD | - | 0.73 | 1.14 |
| 2024/12/31 | Annual | 3B USD | 281M USD | -703M USD | - | 2.61 | -6.53 |
| 2023/12/31 | Annual | 3B USD | 251M USD | 22B USD | 4B USD | -11.26 | 30.56 |
| 2022/12/31 | Annual | 10B USD | -17B USD | -3B USD | 626M USD | -27.68 | -4.29 |
| 2021/12/31 | Annual | - | - | - | - | - | - |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.